Business News Highlights: Awareness about retirement planning rising in urban India, says report
5 mins read | Updated on October 16, 2024, 19:13 IST
SUMMARY
Stay tuned for live updates on the latest business news, trends, and breaking developments on October 16, 2024.
Awareness about retirement planning rising in urban India: Report
Awareness about retirement planning has been rising in urban India with a growing number of people feeling the need to start planning for their post-work life early, a report said.
As many as 44 percent Indians consider the right age to start planning for retirement to be before 35 years, as per the India Retirement Index Study (IRIS) released by Max Life Insurance.
October 16, 2024, 19:13 PM
Blinkit introduces 10-minute Easy Returns service for clothing, footwear in key cities
Blinkit has rolled out a new service that allows customers to return and exchange products for clothing and footwear in under 10 minutes in some select cities across the country.
October 16, 2024, 18:11 PM
Ministers' panel discusses merger of GST compensation cess into taxes
The group of ministers (GoM) on GST compensation cess, under Minister of State for Finance Pankaj Chaudhary, on Wednesday discussed merger of compensation cess into GST.
States suggested that during the transition of cess, once it is decided to merge with taxes no new goods should be added to the list of luxury, sin and demerit goods.
October 16, 2024, 15:23 PM
Adani Green defers $1.2 billion bond sale
Billionaire Gautam Adani's conglomerate deferred a $1.2 billion bond offering to post US elections due to weak market conditions, sources said.
October 16, 2024, 15:20 PM
Wockhardt approaches DCGI for marketing approval for diabetes drug
Drug firm Wockhardt on Wednesday said it has approached the DCGI for marketing approval of a diabetes treatment medication.
The company has filed its fast-acting insulin analog, Aspart injection, with the Drugs Controller General of India (DCGI), the Mumbai-based drug firm said in a regulatory filing.
"We are proud of adding another feather in our diabetes biosimilars portfolio through filing of insulin Aspart injection in a market that has limited competition," Wockhardt Founder Chairman Habil Khorakiwala said.
October 16, 2024, 11:52 AM